Kara Galer
Harvard University
5 Papers
9 Citations
Kara Galer is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions
Nicolas A Menzies,Emory E Wolf,David Connors,Meghan Bellerose,Alyssa N. Sbarra,Ted Cohen,Andrew N. Hill,Reza Yaesoubi,Kara Galer,Peter J White,Peter J White,Ibrahim Abubakar,Joshua A. Salomon,Joshua A. Salomon +13 more
TL;DR: Greater attention to reproducing known features of epidemiology would strengthen future tuberculosis modelling studies, and readers of modelling studies are recommended to assess how well those studies demonstrate their validity.
The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review
Minttu M Rönn,Emory E Wolf,Harrell W. Chesson,Nicolas A Menzies,Kara Galer,Rachel Gorwitz,Thomas L. Gift,Katherine K. Hsu,Joshua A. Salomon +8 more
TL;DR: A review of published chlamydia models to understand the range of approaches used for policy analyses and how the studies have responded to developments in the field and gives a perspective on how mathematical modeling has responded to increasing empirical evidence.
The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000-2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model.
Minttu M Rönn,Ashleigh R. Tuite,Nicolas A Menzies,Emory E Wolf,Thomas L. Gift,Harrell W. Chesson,Elizabeth Torrone,Andrés A. Berruti,Emanuele Mazzola,Kara Galer,Katherine K. Hsu,Joshua A. Salomon,Joshua A. Salomon +12 more
TL;DR: A novel sex- and age-stratified pair-formation transmission model of chlamydial infection is calibrated to epidemiologic data in the United States for 2000–2015 and chlamydia screening and partner notification were both found to reduce chlam Lydia burden.
21
Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model.
Ashleigh R. Tuite,Minttu M Rönn,Emory E Wolf,Thomas L. Gift,Harrell W. Chesson,Andrés A. Berruti,Kara Galer,Nicolas A Menzies,Katherine K. Hsu,Joshua A. Salomon +9 more
TL;DR: Screening for gonorrhea from 2000 to 2015 averted 30% (95% credible intervals, 18–44%) of total infections that would otherwise have occurred, suggesting that screening has reduced Gonorrhea incidence in the US population.
Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.
Nicolas A Menzies,Ted Cohen,Andrew N. Hill,Reza Yaesoubi,Kara Galer,Emory E Wolf,Suzanne M. Marks,Joshua A. Salomon,Joshua A. Salomon +8 more
TL;DR: TB elimination in the United States remains a distant goal, however, strengthening TB prevention and treatment could produce important health benefits and were robust to alternative interpretations of epidemiologic evidence.